Bloomberg Citadel Securities LLC agreed to pay a 670 million-yuan ($97 million) settlement for alleged trading irregularities during the 2015 market rout in China. The settlement was announced by the China Securities Regulatory Commission in a statement on its website. With that, the regulator has ended investigation into suspected account and asset management rule violations, it said, without giving more ...
Read More »Blog Layout
Sluggish bond market is a headache for Indian firms
Bloomberg India needs a bigger bond market now more than ever, to help get funds to cash-strapped companies cut off from their shadow lenders by a crisis in that sector. But a Bloomberg survey shows that sales of local rupee corporate notes will grow only 2% this year, a similar rate to 2019 that’s historically low. India’s corporate bond market ...
Read More »World’s biggest producer of plastic is all set to curtail its use
Bloomberg China will curtail its consumption of single-use plastic in an effort to tackle a soaring amount of the discarded material that has quickly become one of the world’s most pressing environmental crises. Non-degradable plastic bags will be banned in places such as supermarkets and shopping malls in major cities, as well as for the country’s ubiquitous food delivery services ...
Read More »HK’s jobless rate rises for third month in Dec
Bloomberg Hong Kong’s jobless rate rose for a third month in December, as the city’s consumption and tourism-related industries remained weak amid the city’s protest-driven recession. The unemployment rate rose to 3.3% for the October to December period, the highest since March 2017. The run of three straight months is the worst spate of increases for the measure since it ...
Read More »Deflation finds no mention in Abe’s annual speech
Bloomberg This was the first time Japanese prime minister Shinzo Abe didn’t even mention the word “deflation†in his annual start-of-the-legislative-session speech to lawmakers, an omission that may help cement a view the Bank of Japan (BOJ) is now under less pressure to meet its elusive price target. In his 41-minute speech on Monday, Abe talked up the upcoming Tokyo ...
Read More »Samsung engineering maven appointed head of world’s top smartphone business
Bloomberg Samsung Electronics Co has appointed Taemoon Roh the head of its smartphone division, tasking a veteran executive with oversight of the world’s largest mobile devices business. Roh, who was formerly the unit’s No. 2 executive, was expected to take over the top job from Koh Dong-Jin from from Monday. Koh remains head of the Korean conglomerate’s IT and mobile ...
Read More »UK, EU draw battle lines as hard part of Brexit begins
Bloomberg If the past three years of Brexit have been difficult and intense, the next 11 months threaten to be even more so. The UK and European Union (EU) are already at odds before they even start thrashing out the terms of their future relationship. British prime minister Boris Johnson views Brexit as an opportunity to break free from what ...
Read More »China deal is Trump’s hedge against damage
Bloomberg Hours before the seven House Democrats managers marched articles of impeachment across the Capitol last week, president Donald Trump secured what he’s relying on to counter any political damage — a cease-fire in the trade war with China. With little chance the Republican-controlled Senate will convict him on two articles of impeachment, the greatest danger to Trump is that ...
Read More »UK house prices post record jump in Jan
Bloomberg Asking prices for UK homes increased by the most for any January on record in a sign that the Conservatives’ December election win boosted confidence, according to property website-operator Rightmove. Values increased 2.3% on the month to an average 306,810 pounds ($400,000) Rightmove said in a report on Monday. In London, they gained 2.1% from a month earlier, a ...
Read More »AstraZeneca treatments win orphan FDA status
Bloomberg Two AstraZeneca Plc cancer drugs received orphan status for treatment of liver cancer, a designation that may eventually speed progress to approval. The US Food and Drug Administration (FDA) granted the special status reserved for rare conditions to Imfinzi, a lung cancer treatment, and tremelimumab, which has been tested in a combination in a variety of cancers, AstraZeneca said ...
Read More »